Xu X - Search Results

1

A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.

Yi ZF, Cho SG, Zhao H, Wu YY, Luo J, Li D, Yi T, Xu X, Wu Z, Liu M. Yi ZF, et al. Among authors: xu x. Int J Cancer. 2009 Feb 15;124(4):843-52. doi: 10.1002/ijc.24027. Int J Cancer. 2009. PMID: 19035465 Free PMC article.

2

[A synthetic peptide selected by bioinformatics inhibits mouse corneal neovascularization].

Zhao H, Yi ZF, Hu HH, Xu X. Zhao H, et al. Among authors: xu x. Zhonghua Yan Ke Za Zhi. 2007 Feb;43(2):151-7. Zhonghua Yan Ke Za Zhi. 2007. PMID: 17459247 Chinese.

3

Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).

Zhao H, Jin H, Li Q, Gu Q, Zheng Z, Wu H, Ye S, Sun X, Xu X, Ho PC. Zhao H, et al. Among authors: xu x. Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5384-95. doi: 10.1167/iovs.08-3163. Epub 2009 Jun 10. Invest Ophthalmol Vis Sci. 2009. PMID: 19515999

4

Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro.

Zheng Z, Chen H, Zhao H, Liu K, Luo D, Chen Y, Chen Y, Yang X, Gu Q, Xu X. Zheng Z, et al. Among authors: xu x. Invest Ophthalmol Vis Sci. 2010 Jan;51(1):64-71. doi: 10.1167/iovs.09-3511. Epub 2009 Aug 20. Invest Ophthalmol Vis Sci. 2010. PMID: 19696171

5

In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.

Su L, Xu X, Zhao H, Gu Q, Zou H. Su L, et al. Among authors: xu x. Biochem Biophys Res Commun. 2010 Jun 11;396(4):1012-7. doi: 10.1016/j.bbrc.2010.05.048. Epub 2010 May 13. Biochem Biophys Res Commun. 2010. PMID: 20471363

6

A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.

Xu Y, Zhao H, Zheng Y, Gu Q, Ma J, Xu X. Xu Y, et al. Among authors: xu x. Mol Vis. 2010 Oct 7;16:1982-95. Mol Vis. 2010. PMID: 21031024 Free PMC article.

7

Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.

Zheng Y, Gu Q, Xu X. Zheng Y, et al. Among authors: xu x. Acta Ophthalmol. 2012 Nov;90(7):e512-23. doi: 10.1111/j.1755-3768.2012.02476.x. Epub 2012 Sep 20. Acta Ophthalmol. 2012. PMID: 22994140 Free article.

8

H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.

Sun Y, Su L, Wang Z, Xu Y, Xu X. Sun Y, et al. Among authors: xu x, xu y. BMC Cell Biol. 2013 Feb 24;14:8. doi: 10.1186/1471-2121-14-8. BMC Cell Biol. 2013. PMID: 23433118 Free PMC article.

9

Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.

Wang Z, Zhao H, Ma JX, Xu X. Wang Z, et al. Among authors: xu x. Cornea. 2014 Apr;33(4):405-13. doi: 10.1097/ICO.0000000000000032. Cornea. 2014. PMID: 24452210

10

Inhibition of high glucose-induced apoptosis by uncoupling protein 2 in human umbilical vein endothelial cells.

He Y, Wang N, Shen Y, Zheng Z, Xu X. He Y, et al. Among authors: xu x. Int J Mol Med. 2014 May;33(5):1275-81. doi: 10.3892/ijmm.2014.1676. Epub 2014 Feb 27. Int J Mol Med. 2014. PMID: 24584700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,933 results

Search Page

Filters